Correlation Between Affimed NV and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Affimed NV and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and Stoke Therapeutics, you can compare the effects of market volatilities on Affimed NV and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Stoke Therapeutics.
Diversification Opportunities for Affimed NV and Stoke Therapeutics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Affimed and Stoke is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Affimed NV i.e., Affimed NV and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Affimed NV and Stoke Therapeutics
Given the investment horizon of 90 days Affimed NV is expected to under-perform the Stoke Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Affimed NV is 1.01 times less risky than Stoke Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Stoke Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 405.00 in Stoke Therapeutics on August 24, 2024 and sell it today you would earn a total of 726.00 from holding Stoke Therapeutics or generate 179.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 99.6% |
| Values | Daily Returns |
Affimed NV vs. Stoke Therapeutics
Performance |
| Timeline |
| Affimed NV |
| Stoke Therapeutics |
Affimed NV and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Affimed NV and Stoke Therapeutics
The main advantage of trading using opposite Affimed NV and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| Affimed NV vs. Lyra Therapeutics | Affimed NV vs. Hookipa Pharma | Affimed NV vs. Cingulate Warrants | Affimed NV vs. SAB Biotherapeutics |
| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |